Of the novel genes, UCP2 is highly down-regulated in treatment failures compared to cures at pre-treatment baseline and has been shown to be involved in fatty acid metabolism that promotes NLRP3 inflammasome activation during sepsis [27]. The gene discussed is UCP2; the disease is Sepsis.